Microsoft's (MSFT) New Reporting Structure Will Help to See CEO Nadella's Mobile, Cloud Vision - FBR
Get Alerts MSFT Hot Sheet
Rating Summary:
52 Buy, 7 Hold, 0 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 11
Join SI Premium – FREE
FBR affirms Microsoft (Nasdaq: MSFT) at Outperform with a price target of $53 after the company updated its financial reporting structure late Monday.
Analyst Daniel H. Ives offered the following commentary on the new reporting structure: In our view, Microsoft's new reporting structure should help investors better measure Nadella's mobile and cloud vision with a focus on Microsoft as a productivity and platform company, a core part of his grand vision laid out to employees this past June. That said, we believe the tide continues to turn in Microsoft's favor heading into FY16, as cloud adoption appears to be picking up major momentum among enterprises of all shapes and sizes with an annual cloud run-rate of $8 billion.
The new operating structure comes at the right time as Microsoft, in our view, is experiencing an inflection in adoption for its core cloud products (e.g., Office 365/Azure), and its scalable global architecture represents a key differentiating factor that should continue to attract an increasing number of subscribers as enterprises evaluate/embrace cloud providers and their services over the coming years. In our opinion this is setting the stage for the Redmond software stalwart to become a leading force in the ongoing secular shift at enterprises from on-premise to cloud solutions and further differentiate itself from many of its traditional, mature IT stalwarts (Oracle, IBM, HP) that are stuck on an "innovation treadmill."
For an analyst ratings summary and ratings history on Microsoft click here. For more ratings news on Microsoft click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Neo4j Announces Collaboration with Microsoft to Advance GenAI and Data Solutions
- Active options: COIN PLTR MSFT META LCID RIVN BA ARM GME GOOGL CLSK SMCI
- 4D Molecular Therapeutics (FDMT) PT Lowered to $63 at BMO Capital, 'uncertainty remains a lingering overhang until the PhIII readout'
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!